---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-051143"
form_type: "8-K"
ticker: "APVO"
cik: "0001671584"
company_name: "Aptevo Therapeutics Inc."
filed_at: "2025-04-04T23:59:59+00:00"
generated_at: "2026-05-23T21:10:16.028366+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Aptevo raises $2.1M in registered direct offering and private placement; existing warrants amended

## Summary
- Sold 1,764,710 shares of common stock and warrants to purchase up to 3,529,420 shares at $1.19/unit.
- Gross proceeds ~$2.1M; net proceeds ~$1.9M after fees; Roth Capital acted as placement agent.
- Amended existing Dec 2024 warrants: exercise price reduced from $9.53 to $1.19 per share.
- Exercise of new and amended warrants requires stockholder approval; warrants expire 5 years from approval date.
- Proceeds for clinical development of product candidates and working capital.

## SEC filing metadata
- accession: 0000950170-25-051143
- form_type: 8-K
- ticker: APVO
- cik: 0001671584
- company_name: Aptevo Therapeutics Inc.
- filed_at: 2025-04-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671584/000095017025051143/0000950170-25-051143-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671584/000095017025051143/apvo-20250403.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-051143
- JSON: https://secwatch.observer/filing/0000950170-25-051143.json
- Plain text: https://secwatch.observer/filing/0000950170-25-051143.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.